State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative

Stefano Bonassi, Barbara Biasotti, Micheline Kirsch-Volders, Siegfried Knasmueller, Errol Zeiger, Sema Burgaz, Claudia Bolognesi, Nina Holland, Philip Thomas, Michael Fenech

Research output: Contribution to journalArticle

Abstract

The study of DNA damage in exfoliated buccal cells is a minimally invasive method for monitoring populations for exposure to genotoxic agents. The presence of micronuclei (MN) and other nuclear anomalies within these cells has been shown to be associated with genetic defects in genome maintenance, accelerated ageing, genotoxic damage and some degenerative diseases. To identify important information gaps regarding these biomarkers, a new initiative was launched within the framework of the HUman MicroNucleus (HUMN) collaborative programme, the HUMNXL project ('XL' designating eXfoLiated cell). An invitation to join the project was sent out together with a questionnaire to all laboratories that have published on the buccal micronucleus assay. Overall, 188 messages were delivered and 58 laboratories from 25 countries agreed to participate (43 contributing data). The questionnaire was designed to collect methodological information regarding the laboratory's performance of the assay and to assess the extent and type of epidemiological data that are routinely collected. The results provide an overview of the most commonly used methods for buccal cell collection and preparation, slide preparation, staining, scoring criteria and an evaluation of epidemiological data, including demographics, genetic background, gender, health status, occupation, exposure, lifestyle and dietary habit. According to this survey, a potential base of 15103 subjects can be included in future pooled analyses. A number of protocol discrepancies emerged, implying that method standardization is a major priority. The results of this survey will contribute to (i) identify technical and epidemiological key variables that impact on buccal MN frequency in human populations, (ii) drive the design of future intra- and interlaboratory validation studies and (iii) determine the role of MN frequency and other biomarkers, in monitoring genomic damage and predicting cancer and other degenerative diseases.

Original languageEnglish
Pages (from-to)295-302
Number of pages8
JournalMutagenesis
Volume24
Issue number4
DOIs
Publication statusPublished - Jul 2009

Fingerprint

Micronucleus Tests
Cheek
Assays
Biomarkers
Monitoring
Standardization
Health Occupations
Validation Studies
Feeding Behavior
Genes
Aging of materials
Health
Population
Health Status
DNA Damage
Life Style
Defects
DNA
Maintenance
Demography

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Bonassi, S., Biasotti, B., Kirsch-Volders, M., Knasmueller, S., Zeiger, E., Burgaz, S., ... Fenech, M. (2009). State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative. Mutagenesis, 24(4), 295-302. https://doi.org/10.1093/mutage/gep019

State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative. / Bonassi, Stefano; Biasotti, Barbara; Kirsch-Volders, Micheline; Knasmueller, Siegfried; Zeiger, Errol; Burgaz, Sema; Bolognesi, Claudia; Holland, Nina; Thomas, Philip; Fenech, Michael.

In: Mutagenesis, Vol. 24, No. 4, 07.2009, p. 295-302.

Research output: Contribution to journalArticle

Bonassi, S, Biasotti, B, Kirsch-Volders, M, Knasmueller, S, Zeiger, E, Burgaz, S, Bolognesi, C, Holland, N, Thomas, P & Fenech, M 2009, 'State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative', Mutagenesis, vol. 24, no. 4, pp. 295-302. https://doi.org/10.1093/mutage/gep019
Bonassi, Stefano ; Biasotti, Barbara ; Kirsch-Volders, Micheline ; Knasmueller, Siegfried ; Zeiger, Errol ; Burgaz, Sema ; Bolognesi, Claudia ; Holland, Nina ; Thomas, Philip ; Fenech, Michael. / State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative. In: Mutagenesis. 2009 ; Vol. 24, No. 4. pp. 295-302.
@article{a9d28371eac641358ee1f3503e3aa016,
title = "State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative",
abstract = "The study of DNA damage in exfoliated buccal cells is a minimally invasive method for monitoring populations for exposure to genotoxic agents. The presence of micronuclei (MN) and other nuclear anomalies within these cells has been shown to be associated with genetic defects in genome maintenance, accelerated ageing, genotoxic damage and some degenerative diseases. To identify important information gaps regarding these biomarkers, a new initiative was launched within the framework of the HUman MicroNucleus (HUMN) collaborative programme, the HUMNXL project ('XL' designating eXfoLiated cell). An invitation to join the project was sent out together with a questionnaire to all laboratories that have published on the buccal micronucleus assay. Overall, 188 messages were delivered and 58 laboratories from 25 countries agreed to participate (43 contributing data). The questionnaire was designed to collect methodological information regarding the laboratory's performance of the assay and to assess the extent and type of epidemiological data that are routinely collected. The results provide an overview of the most commonly used methods for buccal cell collection and preparation, slide preparation, staining, scoring criteria and an evaluation of epidemiological data, including demographics, genetic background, gender, health status, occupation, exposure, lifestyle and dietary habit. According to this survey, a potential base of 15103 subjects can be included in future pooled analyses. A number of protocol discrepancies emerged, implying that method standardization is a major priority. The results of this survey will contribute to (i) identify technical and epidemiological key variables that impact on buccal MN frequency in human populations, (ii) drive the design of future intra- and interlaboratory validation studies and (iii) determine the role of MN frequency and other biomarkers, in monitoring genomic damage and predicting cancer and other degenerative diseases.",
author = "Stefano Bonassi and Barbara Biasotti and Micheline Kirsch-Volders and Siegfried Knasmueller and Errol Zeiger and Sema Burgaz and Claudia Bolognesi and Nina Holland and Philip Thomas and Michael Fenech",
year = "2009",
month = "7",
doi = "10.1093/mutage/gep019",
language = "English",
volume = "24",
pages = "295--302",
journal = "Mutagenesis",
issn = "0267-8357",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - State of the art survey of the buccal micronucleus assay- A first stage in the HUMNXL project initiative

AU - Bonassi, Stefano

AU - Biasotti, Barbara

AU - Kirsch-Volders, Micheline

AU - Knasmueller, Siegfried

AU - Zeiger, Errol

AU - Burgaz, Sema

AU - Bolognesi, Claudia

AU - Holland, Nina

AU - Thomas, Philip

AU - Fenech, Michael

PY - 2009/7

Y1 - 2009/7

N2 - The study of DNA damage in exfoliated buccal cells is a minimally invasive method for monitoring populations for exposure to genotoxic agents. The presence of micronuclei (MN) and other nuclear anomalies within these cells has been shown to be associated with genetic defects in genome maintenance, accelerated ageing, genotoxic damage and some degenerative diseases. To identify important information gaps regarding these biomarkers, a new initiative was launched within the framework of the HUman MicroNucleus (HUMN) collaborative programme, the HUMNXL project ('XL' designating eXfoLiated cell). An invitation to join the project was sent out together with a questionnaire to all laboratories that have published on the buccal micronucleus assay. Overall, 188 messages were delivered and 58 laboratories from 25 countries agreed to participate (43 contributing data). The questionnaire was designed to collect methodological information regarding the laboratory's performance of the assay and to assess the extent and type of epidemiological data that are routinely collected. The results provide an overview of the most commonly used methods for buccal cell collection and preparation, slide preparation, staining, scoring criteria and an evaluation of epidemiological data, including demographics, genetic background, gender, health status, occupation, exposure, lifestyle and dietary habit. According to this survey, a potential base of 15103 subjects can be included in future pooled analyses. A number of protocol discrepancies emerged, implying that method standardization is a major priority. The results of this survey will contribute to (i) identify technical and epidemiological key variables that impact on buccal MN frequency in human populations, (ii) drive the design of future intra- and interlaboratory validation studies and (iii) determine the role of MN frequency and other biomarkers, in monitoring genomic damage and predicting cancer and other degenerative diseases.

AB - The study of DNA damage in exfoliated buccal cells is a minimally invasive method for monitoring populations for exposure to genotoxic agents. The presence of micronuclei (MN) and other nuclear anomalies within these cells has been shown to be associated with genetic defects in genome maintenance, accelerated ageing, genotoxic damage and some degenerative diseases. To identify important information gaps regarding these biomarkers, a new initiative was launched within the framework of the HUman MicroNucleus (HUMN) collaborative programme, the HUMNXL project ('XL' designating eXfoLiated cell). An invitation to join the project was sent out together with a questionnaire to all laboratories that have published on the buccal micronucleus assay. Overall, 188 messages were delivered and 58 laboratories from 25 countries agreed to participate (43 contributing data). The questionnaire was designed to collect methodological information regarding the laboratory's performance of the assay and to assess the extent and type of epidemiological data that are routinely collected. The results provide an overview of the most commonly used methods for buccal cell collection and preparation, slide preparation, staining, scoring criteria and an evaluation of epidemiological data, including demographics, genetic background, gender, health status, occupation, exposure, lifestyle and dietary habit. According to this survey, a potential base of 15103 subjects can be included in future pooled analyses. A number of protocol discrepancies emerged, implying that method standardization is a major priority. The results of this survey will contribute to (i) identify technical and epidemiological key variables that impact on buccal MN frequency in human populations, (ii) drive the design of future intra- and interlaboratory validation studies and (iii) determine the role of MN frequency and other biomarkers, in monitoring genomic damage and predicting cancer and other degenerative diseases.

UR - http://www.scopus.com/inward/record.url?scp=67650921921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650921921&partnerID=8YFLogxK

U2 - 10.1093/mutage/gep019

DO - 10.1093/mutage/gep019

M3 - Article

C2 - 19477934

AN - SCOPUS:67650921921

VL - 24

SP - 295

EP - 302

JO - Mutagenesis

JF - Mutagenesis

SN - 0267-8357

IS - 4

ER -